Flash FinanceUS
Market closed S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · Ardent Health, Inc. (ARDT)

Ardent Health cuts 2025 Adjusted EBITDA to $447.3 million from $545.0 million

Negative Impact 3 of 5 other Written later

Ardent Health is revising its non-GAAP Adjusted EBITDA and Adjusted EBITDAR for 2025, removing $97.7 million of adjustments tied to two third-quarter 2025 items, following discussions with the SEC staff. The company says GAAP results, net income, cash flows, and 2026 results are unaffected, but the lower adjusted figures change how the company's 2025 performance measures are presented to investors.

Key points

  • Adjusted EBITDA for 2025 decreased from $545.0 million to $447.3 million
  • Adjusted EBITDAR for 2025 decreased from $709.3 million to $611.6 million
  • The $97.7 million removed relates to an accounts receivable collectability estimate change and a New Mexico professional liability accrual, both limited to Q3 2025
  • GAAP results, net income, and 2026 Adjusted EBITDA and EBITDAR are stated as unchanged

The filing

CompanyArdent Health, Inc. (ARDT)
Form8-K, current report
Filed with the SECSep 4, 2026, 4:16 PM ET
Accession number0001628280-26-060735

Items reported: 8.01 Other Events

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 11:43 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on September 04, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.